{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:55:30Z","timestamp":1790744130589,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1053\/j.ajkd.2022.05.008","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:01:54Z","timestamp":1657324914000},"page":"677-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon"],"prefix":"10.1053","volume":"80","author":[{"given":"Giorgio","family":"Trivioli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Angelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Ravaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Allinovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Caroti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Buccoliero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Gattorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Romagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.ajkd.2022.05.008_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"10","key":"10.1053\/j.ajkd.2022.05.008_bib2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2022.05.008_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1546-0096-12-44","article-title":"Mutations in CECR1 associated with a neutrophil signature in peripheral blood","volume":"12","author":"Belot","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1053\/j.ajkd.2022.05.008_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12969-017-0193-x","article-title":"Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation","volume":"15","author":"Skrabl-Baumgartner","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1053\/j.ajkd.2022.05.008_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3899\/jrheum.180045","article-title":"Variable clinical phenotypes and relation of interferon signature with disease activity in ADA2 deficiency","volume":"46","author":"Insalaco","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1053\/j.ajkd.2022.05.008_bib6","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2022.05.008_bib7","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1053\/j.ajkd.2022.05.008_bib8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1474-4422(13)70258-8","article-title":"Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study","volume":"12","author":"Rice","year":"2013","journal-title":"Lancet Neurol"},{"issue":"14","key":"10.1053\/j.ajkd.2022.05.008_bib9","doi-asserted-by":"crossref","first-page":"7776","DOI":"10.1128\/JVI.00546-06","article-title":"Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling","volume":"81","author":"Holzinger","year":"2007","journal-title":"J\u00a0Virol"},{"issue":"10","key":"10.1053\/j.ajkd.2022.05.008_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2022.05.008_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3899\/jrheum.181384","article-title":"A\u00a0monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2","volume":"47","author":"Ozen","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1053\/j.ajkd.2022.05.008_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/art.41500","article-title":"Deficiency of adenosine deaminase 2 in adults and children: experience from India","volume":"73","author":"Sharma","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1053\/j.ajkd.2022.05.008_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2021.01.018","article-title":"Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation","volume":"148","author":"Nihira","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1053\/j.ajkd.2022.05.008_bib14","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0948","article-title":"Renal amyloidosis in deficiency of adenosine deaminase 2: successful experience with canakinumab","volume":"142","author":"Kisla Ekinci","year":"2018","journal-title":"Pediatrics"},{"issue":"6","key":"10.1053\/j.ajkd.2022.05.008_bib15","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1053\/j.ajkd.2022.05.008_bib16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1053\/j.ajkd.2021.02.330","article-title":"Collapsing glomerulopathy as a complication of type i interferon-mediated glomerulopathy in a patient with RNASEH2B-related Aicardi-Goutieres syndrome","volume":"78","author":"Fenaroli","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2022.05.008_bib17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.kint.2022.02.031","article-title":"Type I interferon-related kidney disorders","volume":"101","author":"Lodi","year":"2022","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2022.05.008_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.2018892752","article-title":"Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2","volume":"134","author":"Carmona-Rivera","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2022.05.008_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000289199","article-title":"Type I interferon: a new player in TNF signaling","volume":"11","author":"Yarilina","year":"2010","journal-title":"Curr Dir Autoimmun"},{"issue":"24","key":"10.1053\/j.ajkd.2022.05.008_bib20","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2016-05-715987","article-title":"Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature","volume":"128","author":"Kavanagh","year":"2016","journal-title":"Blood"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622007673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638622007673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:44:34Z","timestamp":1759463074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638622007673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0272638622007673"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.05.008","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2022.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}